Thank you! Your submission has been received!
Close Form
Oops! Something went wrong while submitting the form.
On Sept. 30, San Francisco-based Assort Health, which says it has created a patient experience platform powered by specialty-specific agentic AI, closed a $76 million Series B financing round. In another example, Duke Health said it would co-develop and test agentic AI products with Trase Systems, with the first phase of development beginning at the Duke Heart Center.
Assort Health, a patient communications automation startup, raised $76m in Series B funding. Lightspeed led, joined by First Round, Chemistry, Felicis, A*, Liquid 2 Ventures, and Quiet Capital.
Series B, led by Lightspeed Venture Partners, will turbocharge company’s rapid growth and extend their lead role in using AI to transform the patient experience
Assort Health’s Assort Ascend summit, scheduled for September 19-21, 2025, in Napa Valley, will unite healthcare and tech leaders to advance AI-driven patient engagement and provider operations, using its platform to eliminate wait times and improve care access.
Assort Health’s Assort Ascend summit, set for September 19-21, 2025, in Napa Valley, will unite healthcare and tech leaders to advance AI-driven patient engagement and operational efficiency, leveraging its platform to eliminate wait times and improve care access.
Assort Health’s Assort Ascend summit, set for September 19-21, 2025, in Napa Valley, will gather healthcare leaders to explore AI-driven solutions for patient engagement and provider operations, addressing challenges like increased wait times with its generative AI platform that eliminates long hold times.
Forbes Cloud 100 Rising Stars 2025 highlights Assort Health, a San Francisco healthcare startup using generative AI to manage 22 million+ patient calls, cutting hold times from 11 to 1 minute.
We are grateful to share that Assort Health was named to Forbes’ Next Billion-Dollar Startups 2025 list.
First Round highlights how Assort’s Voice AI agent is setting the standard for accuracy and trust in healthcare automation. The piece underscores our unprecedented achievement, solving over 900,000 real-world edge cases in patient scheduling and communication. This rigor was built by working specialty-by-specialty, practice-by-practice, to create an AI system that can handle the complexity of healthcare workflows with near-flawless precision. Our approach transforms technical challenges into powerful competitive moats, fueled by proprietary data and relentless governance.
Assort Health, a developer of voice AI for handling patient calls, raised $26 million co-led by First Round Capital and Chemistry.
.svg)
Funding news of note: Assort Health secures $26M to expand specialty-specific generative AI platform for managing patient phone calls
Voice AI startup Assort Health secured $26M of growth funding to replace healthcare’s notoriously brutal phone trees and hold times with intelligent triage and scheduling.
We’ve all been there. Your symptoms flare up again and you call your doctor, hoping for a quick referral to a specialist. After several minutes of hold music, someone finally picks up — only to put you on hold again while they check your information. You get an appointment, but later discover you didn’t have the right authorization from your insurance provider or were sent to the wrong specialist — a frustratingly common scenario.
Assort Health, the most advanced specialty-specific AI platform for managing patient phone calls, announced a new round of institutional financing co-led by First Round Capital and Chemistry, with participation from existing investor Quiet Capita
Assort Health, an AI platform for specialty-specific patient call management, secured $26 million in a funding round co-led by First Round Capital and Chemistry, with Quiet Capital and existing investors like Four Acres, Tau Ventures, and prominent angel investors from Athena Health, Flatiron Health, and others.
Assort Health, a leading AI platform for managing specialty-specific patient phone calls, announced the successful completion of a $22 million Series A funding round. The round was co-led by First Round Capital and Chemistry, with additional support from existing partner Quiet Capital.
Assort Health, a company specializing in AI solutions for managing patient phone calls in healthcare, has announced a new round of institutional financing co-led by First Round Capital and Chemistry, with continued support from existing investor Quiet Capital, bringing the company’s total funding to $26M.
Jon Wang and Jeff Liu met dozens of prospective cofounders—until they met each other. Wang had left medical school years earlier to pursue a startup career, while Liu was a former Facebook engineer. They were looking to begin their lives anew as founders of their own startup, and lived more than 2,500 miles apart, with Liu in San Francisco and Wang in New York.
Assort Health, a startup building voice AI agents for healthcare, has raised its $22 million Series A led by First Round and Chemistry.
Assort Health Secures $26 Million in Funding to Expand Specialty-Specific Generative AI Platform for Managing Patient Phone Calls
CMS Launches a new payment model, MA Final Rate notice watch, Modern Health Shutdown, and more
